CTIS.eu › Cities › Austria › Innsbruck
Innsbruck
Austria
347 total trials
153 recruiting
2023-509576-42-00
5
2019-02-21
Patients with resectable Non-small Cell Lung Cancer (Stage IIA to IIIB
2022-502937-24-00
5
2019-01-02
Atopic Dermatitis
2023-507657-15-00
5
2018-09-13
Ulcerative Colitis
2024-515783-31-00
5
2018-08-24
Newly Diagnosed Multiple Myeloma
2023-505341-23-00
5
2018-07-27
Non-muscle invasive bladder cancer
2023-509856-32-00
5
2018-07-15
acute lymphoblastic leukemia in children and adolescents
2023-509976-40-00
5
2018-05-28
Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
2023-509004-15-00
10
2018-02-20
Patients with non-small cell lung cancer (NSCLC).
2024-513070-21-00
4
2018-02-15
Relapsed Acute Lymphoblastic Leukemia (ALL)
2024-515499-12-00
5
2017-10-02
Acute lymphoblastic leukemia
2023-505509-18-00
5
2017-07-12
mature aggressive B-cell lymphoma and leukemia in children and adolesc
2023-509671-17-00
5
2017-07-12
Breast Cancer
2024-513548-27-00
4
2016-10-05
Parkinson's disease
2024-514841-12-00
5
2015-10-27
To determine whether the addition of palbociclib to adjuvant endocrine
2024-511096-15-00
5
2014-08-01
Breast Cancer
2023-507220-23-00
5
2024-07-26
Transthyretin Amyloidosis with Cardiomyopathy
2023-505829-14-00
5
2023-12-22
First recurrence glioblastoma
2023-507680-19-00
4
2024-11-28
Sjögren’s Syndrome
2023-509198-22-00
5
2024-10-21
Thyroid Eye Disease (TED)
2024-511998-30-00
5
2024-10-18
Narcolepsy with Cataplexy (Narcolepsy Type 1)
2023-507376-50-00
1
2024-09-27
Ulcerative Colitis
2023-508679-34-00
4
2024-07-30
Ulcerative Colitis
2023-505903-22-00
4
2024-07-02
Sepsis associated acute kidney injury
2023-505893-14-00
5
2024-06-04
Progressive Supranuclear Palsy
Showing 265–288 of 347 trials